Inmunología, Oftalmología y ORL
Departamento
ANTONIO
LALUEZA BLANCO
Profesor asociado de Ciencias de la Salud
Publicaciones en las que colabora con ANTONIO LALUEZA BLANCO (16)
2024
-
Corrigendum: Immune dysregulation is an important factor in the underlying complications in Influenza infection. ApoH, IL-8 and IL-15 as markers of prognosis(Front. Immunol., (2024), 15, (1443096), 10.3389/fimmu.2024.1443096)
Frontiers in Immunology
-
Immune dysregulation is an important factor in the underlying complications in Influenza infection. ApoH, IL-8 and IL-15 as markers of prognosis
Frontiers in Immunology, Vol. 15
2022
-
An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution
Biomedicines, Vol. 10, Núm. 2
-
Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19
International Journal of Infectious Diseases, Vol. 117, pp. 56-64
-
Effective Natural Killer Cell Degranulation Is an Essential Key in COVID-19 Evolution
International Journal of Molecular Sciences, Vol. 23, Núm. 12
-
Shorter telomere length is associated with COVID-19 hospitalization and with persistence of radiographic lung abnormalities
Immunity and Ageing, Vol. 19, Núm. 1
2021
-
A short corticosteroid course reduces symptoms and immunological alterations underlying long-COVID
Biomedicines, Vol. 9, Núm. 11
-
Alterations in circulating monocytes predict covid-19 severity and include chromatin modifications still detectable six months after recovery
Biomedicines, Vol. 9, Núm. 9
-
Beta-2-Glycoprotein-I Deficiency Could Precipitate an Antiphospholipid Syndrome-like Prothrombotic Situation in Patients With Coronavirus Disease 2019
ACR Open Rheumatology, Vol. 3, Núm. 4, pp. 267-276
-
Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome
Frontiers in Immunology, Vol. 12
-
Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study
International Journal of Infectious Diseases, Vol. 105, pp. 487-494
-
Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study
International Journal of Infectious Diseases, Vol. 105, pp. 319-325
-
Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination
PLoS Pathogens, Vol. 17, Núm. 12
-
SARS-CoV-2-specific T-cell responses after COVID-19 recovery in patients with rheumatic diseases on immunosuppressive therapy
Seminars in Arthritis and Rheumatism, Vol. 51, Núm. 6, pp. 1258-1262
-
T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression
Frontiers in Cellular and Infection Microbiology, Vol. 11
2013
-
Miltefosine-induced acute interstitial pneumonitis in a patient with renal dysfunction
International Journal of Infectious Diseases